TY - JOUR
T1 - Neurologic complications of COVID-19
AU - Hassett, Catherine E.
AU - Gedansky, Aron
AU - Migdady, Ibrahim
AU - Bhimraj, Adarsh
AU - Uchino, Ken
AU - Cho, Sung Min
N1 - Publisher Copyright:
© 2020. All Rights Reserved.
PY - 2020/12
Y1 - 2020/12
N2 - Patients with COVID-19 have a fairly high risk of neurologic complications, including encephalopathy, stroke, central nervous system infection, seizures, and neuromuscular diseases. Many report losing their senses of smell and taste, and many survivors report lingering neurocognitive impairment. The diagnosis and treatment of these complications does not differ from that in other patients, although sophisticated testing may not be readily available for a patient in intensive care and respiratory isolation. Clinicians should therefore be alert to these complications.
AB - Patients with COVID-19 have a fairly high risk of neurologic complications, including encephalopathy, stroke, central nervous system infection, seizures, and neuromuscular diseases. Many report losing their senses of smell and taste, and many survivors report lingering neurocognitive impairment. The diagnosis and treatment of these complications does not differ from that in other patients, although sophisticated testing may not be readily available for a patient in intensive care and respiratory isolation. Clinicians should therefore be alert to these complications.
KW - Human coronaviruses
KW - can be neurotropic
KW - including SARS-CoV-2
UR - http://www.scopus.com/inward/record.url?scp=85096815464&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85096815464&partnerID=8YFLogxK
U2 - 10.3949/ccjm.87a.ccc058
DO - 10.3949/ccjm.87a.ccc058
M3 - Article
C2 - 32847818
AN - SCOPUS:85096815464
SN - 0891-1150
VL - 87
SP - 729
EP - 734
JO - Cleveland Clinic journal of medicine
JF - Cleveland Clinic journal of medicine
IS - 12
ER -
